Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002005369-25-000046·Invus Global Management, LLC
Schedule 13G ownership disclosure
VTV THERAPEUTICS INC
Class A Common Stock, $0.01 par value per share · CUSIP: 918385204
Event date: 2025-08-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Invus Public Equities, L.P.
Shares: 306,313.00 · Class: 8.8%
- Invus Public Equities Advisors, LLC
Shares: 306,313.00 · Class: 8.8%
- Invus Global Management, LLC
Shares: 306,313.00 · Class: 8.8%
- Siren, L.L.C.
Shares: 306,313.00 · Class: 8.8%
- Avicenna Life Sci Master Fund LP
Shares: 41,770.00 · Class: 1.3%
- Avicenna Life Sci Master GP LLC
Shares: 41,770.00 · Class: 1.3%
- Ulys, L.L.C.
Shares: 41,770.00 · Class: 1.3%
- Raymond Debbane
Shares: 348,083.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002005369-25-000046
- Form type
- SCHEDULE 13G
- Filer
- Invus Global Management, LLC
- CIK
- CIK 2005369
- Filed
- Sep 08, 2025
- Reporting period
- Aug 29, 2025
- Description
- Schedule 13G beneficial ownership